Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 396.00
Bid: 390.00
Ask: 400.00
Change: 4.00 (1.02%)
Spread: 10.00 (2.564%)
Open: 391.00
High: 400.00
Low: 390.00
Prev. Close: 392.00
WIL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Health Service Journal

19 Jan 2017 07:04

RNS Number : 5826U
Wilmington PLC
19 January 2017
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION for the purposes of Article 7 of EU Regulation 596/2014.

19 January 2017

Wilmington plc

 

Acquisition of Health Service Journal

- Significantly strengthens Wilmington's presence across the UK healthcare market -

- Acquisition brings positive cross-sell opportunities and recurring revenue streams -

Wilmington plc ("Wilmington" or the "Group"), the knowledge leader in Risk & Compliance, Finance, Legal, and Insight, announces it has reached agreement to acquire the Health Service Journal ("HSJ" and the "Acquisition"), the UK's leading health information, insight and networking business, from Ascential plc for £19m with an adjustment for working capital, payable on completion. The consideration is to be funded from the Group's existing debt facilities. The Acquisition is expected to complete on 31 January 2017.

The Acquisition is consistent with Wilmington's strategy of acquiring complementary businesses with high levels of recurring revenues and strong cash generation. HSJ will sit within Wilmington's Insight division, aligned with Wilmington Healthcare and will position Wilmington as the leading provider of insight, analytics, networking and education in UK Healthcare; one of the priority areas for the Group's capital allocation.

Background to HSJ

HSJ is the UK's leading health information, insight and networking business with a highly trusted brand providing unparalleled penetration into the NHS and private vendor space through subscription information and data products, events and awards and marketing solutions.

HSJ has a growing recurring revenue stream from subscriptions and annual events which last year represented around 70% of total revenue (*1). The existing management team, led by Andy Baker and Alastair McLellan, will remain with the business and are included within the c60 employees anticipated to transfer across to the Group with HSJ.

HSJ's key products are:

· HSJ.co.uk: HSJ's flagship digital information product is the UK's premier source of proprietary content, insight, comment and analysis on the UK healthcare sector. HSJ Online has approximately 17,000 users and is sold on an individual and increasingly corporate subscription basis. HSJ Online is widely recognised for its thought leadership in the UK healthcare sector.

 

· HSJ Intelligence: a fast growing digital data subscription product with approximately 20,000 data points, which was launched in 2014. It already has 115 enterprise customers from across the healthcare industry and presents a significant growth opportunity for HSJ.

 

· HSJ Events: 11 annual networking events including awards, large scale conferences and summits and the flagship Health Service Journal Awards event.

 

· HSJ Marketing Services: targeted marketing solutions for the healthcare industry and a legacy digital recruitment offering.

 

Acquisition rationale

The HSJ business will be integral to Wilmington's market leading healthcare business significantly enhancing the Group's presence across the UK healthcare market. Uniquely, Wilmington Healthcare will have a complete UK industry presence across both provider/payer and the private sector in Pharma and MedTech and other healthcare providers.

Healthcare expenditure is inexorably rising and businesses need the solutions that Wilmington Healthcare provides to optimise their activities. The acquisition of HSJ will enhance Wilmington's access to senior decision makers and access to a wider group of healthcare stakeholders who will benefit from the combined business's enhanced solutions.

The Acquisition brings clear cross-selling opportunities to the Group with attractive options to expand its services. By way of example, this is likely to include the combining of qualitative and quantitative analysis to support clients, including the NHS. Wilmington will align the HSJ events business with its other Insight events operations to offer an even wider range of networking opportunities and events.

HSJ's revenue is principally of a high quality recurring nature as a result of its growing subscription revenue base supported by annual events and, to an increasingly lesser extent, marketing services.

Financial impact

The Acquisition is expected to be earnings per share enhancing in the first full year of ownership. HSJ revenue for the 12 months ended 31 December 2016 was £10m with pro-forma contribution before Group overheads of £4.4m. HSJ's gross assets at 30 June 2016 were £12.8m including intangible assets.

Extension of banking facility

The Group has also exercised its option to activate an accordion facility which provides it additional headroom of £20m on its existing multicurrency debt facility, increasing the total level of that facility to £85m.

 

Commenting on the acquisition Pedro Ros, Chief Executive of Wilmington plc, said:

"I am pleased to be announcing this acquisition of Health Service Journal, which represents an exciting opportunity for Wilmington to acquire a brand of exceptional status in the UK Healthcare market, a primary source of critical information and insight to senior management and decision-makers in the NHS and wider healthcare sector.

I'm delighted to welcome Health Service Journal to Wilmington, a highly complementary and earnings enhancing acquisition. Together with our Wilmington Healthcare business, the combination will become a central presence across the UK healthcare market. This will open up a number of important cross-selling and networking opportunities for us to provide even more powerful, market leading insight to our clients."

Alastair McLellan, Editor of HSJ, said:

"We are very pleased to be joining Wilmington and we look forward to providing critical information and insight to the healthcare industry under new ownership. Collaborating together with Wilmington's existing Healthcare business will bring a range of new information service and networking opportunities and we look forward to the challenge with confidence." 

Andy Baker Managing Director of HSJ added:

"HSJ is highly respected for the quality of its content and its journalism and the acquisition will further support Wilmington's market leading content acquisition and analysis. It's incredibly exciting for HSJ to be joining a business as committed to healthcare as Wilmington and I think it bodes extremely well for HSJ's subscribers and customers."

 

[1] Unaudited pro-forma based on management information for the year to 31 December 2016

[2] Unaudited pro-forma based on management information at 31 December 2016

 

For further information please contact:

Wilmington plc

Tel: 020 7422 6800

Pedro Ros, Chief Executive Officer

 

Tony Foye, Chief Financial Officer

 

 

 

Numis Securities Limited (Sole Financial Adviser to Wilmington)

Tel: 0207 260 1200

Nick Westlake

 

Lorna Tilbian

 

Mark Lander

 

Hugo Rubinstein

 

 

 

FTI Consulting

Tel: 020 3727 1000

Charles Palmer

 

Emma Appleton

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUKOSRBWAAARR
Date   Source Headline
3rd Feb 201210:55 amRNSVoting Rights and Capital
4th Jan 20123:45 pmRNSTotal Voting Rights
8th Dec 20113:30 pmRNSDirector/PDMR Shareholding
6th Dec 20114:16 pmRNSHolding(s) in Company
6th Dec 20114:15 pmRNSHolding(s) in Company
6th Dec 20114:15 pmRNSHolding(s) in Company
1st Dec 20112:45 pmRNSNotice of Results
1st Dec 20112:30 pmRNSAnnual Information Update
1st Dec 201110:45 amRNSTotal Voting Rights
16th Nov 20113:00 pmRNSBoard Changes
15th Nov 20114:30 pmRNSResult of AGM
15th Nov 201111:00 amRNSHolding(s) in Company - Amendment
15th Nov 20117:00 amRNSInterim Management Statement
14th Nov 20115:00 pmRNSHolding(s) in Company
7th Nov 201112:15 pmRNSBlocklisting Interim Review
1st Nov 20112:00 pmRNSTotal Voting Rights
24th Oct 20114:15 pmRNSAnnual Report and Financial Statements 2011
20th Oct 20114:15 pmRNSDirector/PDMR Shareholding
3rd Oct 201112:15 pmRNSTotal Voting Rights
29th Sep 20117:00 amRNSDirector/PDMR Shareholding
21st Sep 201111:07 amRNSDirector/PDMR Shareholding
20th Sep 20117:00 amRNSFinal Results
2nd Sep 20112:18 pmRNSVoting Rights and Capital
1st Aug 20113:14 pmRNSTotal Voting Rights
25th Jul 20113:30 pmRNSNotice of Results
14th Jul 20117:00 amRNSPre Close Trading Update
13th Jul 20113:38 pmRNSAdditional Listing
4th Jul 201112:06 pmRNSVoting Rights and Capital
27th Jun 201112:30 pmRNSCompletion of Bank Refinancing
17th Jun 201110:33 amRNSDirector/PDMR Shareholding
2nd Jun 20119:23 amRNSVoting Rights and Capital
18th May 20117:00 amRNSInterim Management Statement
9th May 20114:37 pmRNSBlocklisting Interim Review
4th May 20117:00 amRNSTotal Voting Rights
21st Apr 20112:27 pmRNSDirector/PDMR Shareholding
20th Apr 20114:47 pmRNSNotification of Interim Management Statement
15th Apr 20112:50 pmRNSNotification of Major Interests in Shares
4th Apr 201111:44 amRNSVoting Rights and Capital
23rd Mar 20114:09 pmRNSTR-1: Notification of Major Interests in Shares
3rd Mar 20114:56 pmRNSHolding(s) in Company
3rd Mar 20113:58 pmRNSHolding(s) in Company
1st Mar 201110:35 amRNSTotal Voting Rights
25th Feb 20117:00 amRNSDividend Dates
24th Feb 20117:00 amRNSHalf Yearly Report
1st Feb 20112:57 pmRNSTotal Voting Rights
26th Jan 20117:00 amRNSReplacement of Joint Broker
24th Jan 20112:26 pmRNSHolding(s) in Company
4th Jan 20113:17 pmRNSTotal Voting Rights
22nd Dec 20102:16 pmRNSDirector/PDMR Shareholding
8th Dec 20103:48 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.